Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer (Biolen + RT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04943536 |
|
Recruitment Status :
Recruiting
First Posted : June 29, 2021
Last Update Posted : October 8, 2021
|
Sponsor:
Alessa Therapeutics Inc.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alessa Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 1, 2024 |
| Estimated Study Completion Date : | December 31, 2024 |